Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$567.98 USD
+5.22 (0.93%)
Updated May 31, 2024 04:00 PM ET
After-Market: $568.45 +0.47 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth A Momentum C VGM
Brokerage Reports
Thermo Fisher Scientific Inc. [TMO]
Reports for Purchase
Showing records 461 - 480 ( 545 total )
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Encouraged by Sustained Momentum in Key End Markets; No Change to LT Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Sequential Rebound in Organic Growth Drives 2Q Beat; Guidance Raised Modestly
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Modestly Raising Estimates and PT; Solid Momentum Heading into 2H
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Modestly Raising 2016 Estimates Due to an Improved LT Organic Growth Outlook
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
A Strategic Interest but Somewhat Skeptical of TMO Need/Capacity
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Managing the FX Impact; EPS Guidance Encouraging
Provider: KEYBANC CAPITAL MARKETS